MWNA
PTVE

Marshall Wace North America’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Marshall Wace North America’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-548,402
Closed -$6.96M – 1645
2020
Q3 		$6.96M Buy
+548,402
New +$6.88M 0.04% 337

Other funds holding PTVE

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Marshall Wace North America's PTVE Position: Q4 2020 in Review

Marshall Wace North America sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2020, closing a stake of 548,402 shares — an estimated $6.96M sold.

Marshall Wace North America first reported a position in PTVE in Q3 2020 and held it in 1 quarter. The position peaked at $6.96M in Q3 2020. 67 funds tracked by Wall St. Rank hold PTVE as of Q4 2020.

  • Marshall Wace North America reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 548,402 Pactiv Evergreen Inc. Common stock shares in Q4 2020, an estimated $6.96M.
  • Marshall Wace North America first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 1 quarter.
  • Marshall Wace North America's Pactiv Evergreen Inc. Common stock position peaked at $6.96M in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.